Suggested Topics within your search.
Suggested Topics within your search.
- Cancer 1
- Immune System 1
- Immunity 1
- Orthopedic surgery 1
- Orthopedics 1
- Pediatrics 1
- Tumors 1
-
241
A Pleural Solitary Fibrous Tumor, Multiple Gastrointestinal Stromal Tumors, Moyamoya Disease, and Hyperparathyroidism in a Patient Associated with NF1
Published 2015-01-01“…Loss of the gene function, due to a point mutation, leads to an increase in cell proliferation and the development of several tumors. We report a 60-year-old female patient manifesting hypercalcemia due to hyperparathyroidism, a solitary fibrous tumor (SFT) of the pleura, multiple gastrointestinal stromal tumors (GISTs), and moyamoya disease associated with NF1. …”
Get full text
Article -
242
Comparative analysis of EGFR mutations in circulating tumor DNA and primary tumor tissues from lung cancer patients using BEAMing PCR
Published 2025-01-01“…Noninvasive mutation detection by assessing circulating tumor DNA (ctDNA) offers many advantages over tumor biopsy. …”
Get full text
Article -
243
Comprehensive single-cell atlas of colorectal neuroendocrine tumors with liver metastases: unraveling tumor microenvironment heterogeneity between primary lesions and metastases
Published 2025-01-01“…Abstract Background Colorectal neuroendocrine tumors with liver metastases (CRNELM) are associated with a poorer prognosis compared to their nonmetastatic counterparts. …”
Get full text
Article -
244
CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment
Published 2025-01-01“…Clinically, CREB3L1 correlated with immune cell signatures as well as immune checkpoint blockade (ICB) treatment response and outcome that CREB3L1aberrant activation indicated poorer efficacy and worse prognosis than the low in PDAC which might empower clinical decision.Conclusions Collectively, this study revealed CREB3L1 facilitated PDAC progression, shaped an immune exclude tumor microenvironment and distinguished therapy response and outcome of ICB therapy indicating CREB3L1 could be a promising novel molecular target and biomarker for PDAC treatment.…”
Get full text
Article -
245
Calpain 2 regulates IL-1α secretion and inhibits tumor development via modulating calpain 1 expression in the tumor microenvironment
Published 2025-12-01Subjects: Get full text
Article -
246
Alleviating Tumor Hypoxia and Immunosuppression via Sononeoperfusion: A New Ally for potentiating anti-PD-L1 blockade of solid Tumor
Published 2025-01-01Subjects: Get full text
Article -
247
-
248
Endoscopic endonasal approach for pituitary neuroendocrine tumor with septal mucosa incision tailored to tumor extension intending unilateral septal mucosa preservation
Published 2025-01-01Subjects: “…Pituitary neuroendocrine tumor…”
Get full text
Article -
249
Tumor hypoxia evidences the differential regulation of Mdm2-p53 axis by PTEN in tumor derived vs. normal endothelial cells
Published 2024-12-01“…The tumor suppressor PTEN regulates angiogenesis, a process involving endothelial cells (ECs). …”
Get full text
Article -
250
Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction
Published 2025-02-01“…Cancer stem cells (CSCs) are a small subset within the tumor mass significantly contributing to cancer progression through dysregulation of various oncogenic pathways, driving tumor growth, chemoresistance and metastasis formation. …”
Get full text
Article -
251
-
252
Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response
Published 2025-01-01Subjects: Get full text
Article -
253
Primary epithelioid trophoblastic tumor of the lung: A case report
Published 2024-04-01Subjects: “…epithelioid trophoblastic tumor (ett)…”
Get full text
Article -
254
PHYLLOID TUMORS OF MAMMARY GLANDS. CURRENT STATE OF THE PROBLEM
Published 2017-06-01Subjects: “…phylloid tumor…”
Get full text
Article -
255
Mature Cystic Teratoma with Neuroendocrine Tumor — Case Report
Published 2025-01-01Subjects: “…Presacral Tumor…”
Get full text
Article -
256
Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer
Published 2011-01-01“…In basal cell carcinoma, the tumor suppressor protein CYLD is repressed at the transcriptional levels through hedgehog signaling pathway. …”
Get full text
Article -
257
Advances and prospects of cell-penetrating peptides in tumor immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
258
Breast Neuroendocrine Tumor. Case Report and Literature Review
Published 2017-04-01“…Primary neuroendocrine carcinomas of the breast are rare neoplasms, accounting for 2 to 5 % of breast tumors. For their diagnosis it is required that more than 50 % of the tumor present neuroendocrine features. …”
Get full text
Article -
259
Mechanisms of T-cell Depletion in Tumors and Advances in Clinical Research
Published 2025-02-01Subjects: Get full text
Article -
260
Active Roles of Tumor Stroma in Breast Cancer Metastasis
Published 2012-01-01“…Metastasis is the major cause of death for breast cancer patients. Tumors are heterogenous cellular entities composed of cancer cells and cells of the microenvironment in which they reside. …”
Get full text
Article